The effect of artificial saliva on the control of dry mouth: a semi-experimental study on COVID-19 patients under Non-invasive mechanical ventilation.
Artificial saliva
COVID-19
ICU patients
Non-invasive mechanical ventilation
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
31 May 2024
31 May 2024
Historique:
received:
21
12
2023
accepted:
20
05
2024
medline:
1
6
2024
pubmed:
1
6
2024
entrez:
31
5
2024
Statut:
epublish
Résumé
Since maintaining oral hygiene is essential in nursing care, the present study was conducted to determine the effect of oral care using Mucosamin artificial saliva spray to control dry mouth in ICU patients with COVID-19. The current semi-experimental research was conducted on eighty patients with COVID-19 selected using the available sampling method. The study tool was a Beck oral assessment scale (BOAS). The case and control groups were selected from two hospitals with relatively similar conditions and treatment procedures. For patients in the intervention group, mucosamin artificial saliva spray was used in addition to the common care, while control group patients received only common care. Eighty patients were randomly assigned to two groups named control and intervention (40 patients in each group). The intervention was very effective in reducing the BOAS score after four days in comparison with the control group (9.23 vs. 12.05, respectively; p-value < 0.001). Based on the adjusted model, the application of artificial saliva reduced the BOAS score, indicating improvement in mouth dryness. While the BOAS score was increased in the control group, it had a declining trend in the intervention one. The study's results showed that using artificial saliva spray could effectively reduce the symptoms of dry mouth in patients with COVID-19 treated with non-invasive mechanical ventilation. The present study introduced an applicable solution (artificial saliva) to treat mouth dryness in ICU patients under mechanical ventilation.
Identifiants
pubmed: 38822326
doi: 10.1186/s12903-024-04386-4
pii: 10.1186/s12903-024-04386-4
doi:
Substances chimiques
Saliva, Artificial
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
643Informations de copyright
© 2024. The Author(s).
Références
Paszynska E, Gawriolek M, Hernik A, Otulakowska-Skrzynska J, Winiarska H, Springer D, et al. Prevalence of oral complications in the course of severe SARS-CoV-2 infection under mechanical non-invasive ventilation. Eur J Med Res. 2023;28(1):293.
doi: 10.1186/s40001-023-01273-6
pubmed: 37608339
pmcid: 10463896
Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis. 2021;27:703–6.
doi: 10.1111/odi.13359
pubmed: 32304276
Wong JP, Viswanathan S, Wang M, Sun L-Q, Clark GC, D’Elia RV. Current and future developments in the treatment of virus-induced hypercytokinemia. Future Med Chem. 2017;9(2):169–78.
doi: 10.4155/fmc-2016-0181
pubmed: 28128003
Fathi Y, Hoseini EG, Atoof F, Mottaghi R. Xerostomia (dry mouth) in patients with COVID-19: a case series. Future Virol. 2021;16(5):315–9.
doi: 10.2217/fvl-2020-0334
Eduardo FP, Bezinelli LM, Gobbi MF, Bergamin LG, de Carvalho DLC, Corrêa L. Oral lesions and saliva alterations of COVID-19 patients in an intensive care unit: a retrospective study. Spec Care Dentist. 2022;42(5):494–502.
doi: 10.1111/scd.12705
pubmed: 35239209
Arany S, Kopycka-Kedzierawski DT, Caprio TV, Watson GE. Anticholinergic medication: related dry mouth and effects on the salivary glands. Oral surgery, oral medicine, oral pathology and oral radiology. 2021;132(6):662–70.
Shafigh E, Fekrazad R, Bahrani MM. Push-out evaluation on metal and Fiber posts using two different types of cement in a hyper-narrow environment. Eur J Gen Dentistry. 2022;11(03):166–72.
doi: 10.1055/s-0042-1749333
Shafigh E, Ashrafi M, A REVIEW OF MECHANICAL, BEHAVIOR OF DENTAL CERAMIC RESTORATIONS. J Mech Med Biology. 2021;21(08):2150063.
doi: 10.1142/S0219519421500639
Sabzehkar F, Mogharab M, Sharifzadeh G, Kiani Z. Comparison of the effect of chamomile and chlorhexidine glucosan cleansing on dental plaque and mucosal lesions of ventilated patients in the intensive care unit. J Birjand Univ Med Sci. 2021;28(2):106–19.
Leite PB, da Silva Coelho A, Rio MI, Freire NA, Ramos MEB, Israel MS. Oral manifestations of covid-19: review of the literature.
Hocková B, Riad A, Valky J, Šulajová Z, Stebel A, Slávik R, et al. Oral complications of ICU patients with COVID-19: case-series and review of two hundred ten cases. J Clin Med. 2021;10(4):581.
doi: 10.3390/jcm10040581
pubmed: 33557130
pmcid: 7913822
Davis B, Davis BD. Caring for people in pain. Routledge; 2002.
Routaray S, Prasad C, Rajagopalan V. Non-invasive ventilation (NIV) induced bilateral subcutaneous emphysema in SARS COV-2 patient: a rare occurrence. Trends Anaesth Crit Care. 2021.
Łysik D, Niemirowicz-Laskowska K, Bucki R, Tokajuk G, Mystkowska J. Artificial saliva: challenges and future perspectives for the treatment of xerostomia. Int J Mol Sci. 2019;20(13):3199.
doi: 10.3390/ijms20133199
pubmed: 31261876
pmcid: 6651665
Rajkumar K, Ramya R, Swarna R. Non pharmacological management for Xerostomia-a systematic review. J Clin Diagn Res. 2019;13:ZE01–5.
Gregorczyk-Maga I, Pałka A, Fiema M, Kania M, Kujawska A, Maga P, et al. Impact of tooth brushing on oral bacteriota and health care-associated infections among ventilated COVID-19 patients: an intervention study. Antimicrob Resist Infect Control. 2023;12(1):17.
doi: 10.1186/s13756-023-01218-y
pubmed: 36890608
pmcid: 9992909
Ribeiro ILA, Bellissimo-Rodrigues WT, Mussolin MG, Innocentini LMAR, Marangoni ATD, Macedo LD, et al. Impact of a dental care intervention on the hospital mortality of critically ill patients admitted to intensive care units: a quasi-experimental study. Am J Infect Control. 2022;50(10):1156–61.
doi: 10.1016/j.ajic.2022.01.022
pubmed: 35108582
Meyer-Lueckel H, Schulte‐Mönting J, Kielbassa A. The effect of commercially available saliva substitutes on predemineralized bovine dentin in vitro. Oral Dis. 2002;8(4):192–8.
doi: 10.1034/j.1601-0825.2002.01762.x
pubmed: 12206400
Ames NJ, Sulima P, Yates JM, McCullagh L, Gollins SL, Soeken K, et al. Effects of systematic oral care in critically ill patients: a multicenter study. Am J Crit Care. 2011;20(5):e103–14.
doi: 10.4037/ajcc2011359
pubmed: 21885453
pmcid: 3383657
Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857–72.
doi: 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
pubmed: 9595616
Piaton S, Duconseille A, Roger-Leroi V, Hennequin M. Could the use of saliva substitutes improve food oral processing in individuals with xerostomia? A systematic review. J Texture Stud. 2021;52(3):278–93.
doi: 10.1111/jtxs.12591
pubmed: 33587294
Ingle EN. Artificial Saliva for Therapeutic Management of Xerostomia: a structured review. J Oral Health Community Dentistry. 2020;14(1).
Sinjari B, Feragalli B, Cornelli U, Belcaro G, Vitacolonna E, Santilli M, et al. Artificial saliva in diabetic xerostomia (ASDIX): double blind trial of Aldiamed® versus placebo. J Clin Med. 2020;9(7):2196.
doi: 10.3390/jcm9072196
pubmed: 32664567
pmcid: 7408818
Banks JM, Capistrano KJ, Brandini DA, Zaidi F, Thakkar P, Rahat R, et al. Herpesviruses and SARS-CoV-2: Viral Association with oral inflammatory diseases. Pathogens. 2024;13(1):58.
doi: 10.3390/pathogens13010058
pubmed: 38251365
pmcid: 10819702
Biadsee A, Biadsee A, Kassem F, Dagan O, Masarwa S, Ormianer Z. covid19? Olfactory and oral manifestations of COVID-19: sex-related symptoms—a potential pathway to early diagnosis. Otolaryngology–Head Neck Surg. 2020;163(4):722–8.
doi: 10.1177/0194599820934380
Pico-Orozco J, Carrasco-Llatas M, Silvestre F-J, Silvestre-Rangil J. Xerostomia in patients with sleep apnea-hypopnea syndrome: a prospective case-control study. J Clin Experimental Dentistry. 2020;12(8):e708.
doi: 10.4317/jced.56593
Rotty M-C, Suehs CM, Mallet J-P, Martinez C, Borel J-C, Rabec C, et al. Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study. Respir Res. 2021;22(1):1–13.
doi: 10.1186/s12931-021-01618-x
Kvalheim SF, Marthinussen MC, Haugen DF, Berg E, Strand GV, Lie SA. Randomized controlled trial of the effectiveness of three different oral moisturizers in palliative care patients. Eur J Oral Sci. 2019;127(6):523–30.
doi: 10.1111/eos.12655
pubmed: 31325345
Lanza L, Falco CE, Gender-Specific CEIJ. Evaluation of the efficacy of an oral spray formulation of hyaluronic acid and amino acids in secondary ‘burning mouth syndrome’from local or general causes, with specific regard to gender. Italian J Gender-Specific Med. 2021;7(2):86–93.
Nasrollahi H, Khaki S, Ansari M, Ahmadloo N, Khanjani N, Hamedi SH, et al. Evaluation of mucosamin effect on treating radiation induced oral mucositis during and after radiotherapy amongst patients with oral cavity squamous cell carcinoma. Asian Pac J Cancer Prevention: APJCP. 2021;22(11):3711.
doi: 10.31557/APJCP.2021.22.11.3711
Zhang W, Gu Q, Gu Y, Zhao Y, Zhu L. Symptom management to alleviate thirst and dry mouth in critically ill patients: a randomised controlled trial. Australian Crit Care. 2022;35(2):123–9.
doi: 10.1016/j.aucc.2021.04.002
Celik GG, Eser I. Examination of intensive care unit patients’ oral health. Int J Nurs Pract. 2017;23(6):e12592.
doi: 10.1111/ijn.12592
Hu J, Andablo-Reyes E, Mighell A, Pavitt S, Sarkar A. Dry mouth diagnosis and saliva substitutes—A review from a textural perspective. J Texture Stud. 2021;52(2):141–56.
doi: 10.1111/jtxs.12575
pubmed: 33274753